Trust Investment Advisors Acquires 2,979 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Trust Investment Advisors increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 55.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,350 shares of the company’s stock after buying an additional 2,979 shares during the quarter. Trust Investment Advisors’ holdings in GE HealthCare Technologies were worth $653,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Cherry Creek Investment Advisors Inc. boosted its stake in shares of GE HealthCare Technologies by 0.3% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky boosted its position in GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after buying an additional 114 shares in the last quarter. Haverford Trust Co grew its stake in shares of GE HealthCare Technologies by 2.4% during the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company’s stock worth $383,000 after buying an additional 115 shares during the last quarter. Tandem Capital Management Corp ADV increased its holdings in shares of GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after buying an additional 118 shares in the last quarter. Finally, Arcus Capital Partners LLC lifted its stake in shares of GE HealthCare Technologies by 3.0% in the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock valued at $322,000 after acquiring an additional 119 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $82.46 on Wednesday. The firm has a market capitalization of $37.71 billion, a P/E ratio of 19.04, a P/E/G ratio of 3.19 and a beta of 1.13. The firm’s 50-day moving average price is $86.91 and its 200-day moving average price is $85.96. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

GEHC has been the topic of several research reports. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.